Interestingly, the gene encoding FOS was downregulated in the SEV group at endpoint B compared to controls at endpoint A (contrast 4), indicating that B12, in addition to blocking the binding of this TF to the regulatory region of CCL3, also reduces its expression in severe COVID-19. This evidence concerns the gene FOS and COVID-19.